FDA Letter API

Healthwest Minerals, Inc. dba Mt. Capra Products

Letter data

Company
Healthwest Minerals, Inc. dba Mt. Capra Products
Recipient
Joseph C. Stout | President | Healthwest Minerals, Inc. dba Mt. Capra Products | 279 Southwest 9th Street | Chehalis | , | WA | 98532-3313 | United States | joe@mtcapra.com
Issue date
2025-09-03
Posted date
Not available
FDA office
Division of Human and Animal Food Operations West VI
Subject
Not available
Product
Dietary Supplements
CMS ID
685115
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Healthwest Minerals, Inc. dba Mt. Capra Products MARCS-CMS 685115 — September 03, 2025 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Delivery Confirmation Product: Dietary Supplements Recipient: Recipient Name Joseph C. Stout Recipient Title President Healthwest Minerals, Inc. dba Mt. Capra Products 279 Southwest 9th Street Chehalis , WA 98532-3313 United States joe@mtcapra.com Issuing Office: Division of Human and Animal Food Operations West VI United States Secondary Issuing Offices United States Dear Mr. Stout: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter CMS 685115, dated September 11, 2024. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Acting Branch Chief Division of Conventional Foods Enforcement – Branch 1 Office of Compliance and Enforcement Human Foods Program Content current as of: 09/08/2025 Regulated Product(s) Dietary Supplements